Moderna Inc (NAS:MRNA)
$ 43.39 1.34 (3.19%) Market Cap: 16.70 Bil Enterprise Value: 10.67 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 66/100

Moderna Inc at Goldman Sachs Healthcare Conference Transcript

Jun 14, 2023 / 11:40PM GMT
Release Date Price: $126.05 (-1.51%)
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

Great. Good afternoon, everyone. Thanks so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. Really pleased to have the team from Moderna here today. So we have Jamie Mock, CFO; and Lavina Talukdar, Head of IR.

Questions & Answers

Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

So with that, maybe we'll start here with some financial questions. You provided some guidance in the beginning of the year and -- on COGS and other aspects. Could you just help us understand what COGS is going to look like for this year and beyond? And what the key components are on this line and how they change over time as commercialize COVID, as that market is better understood and then additional assets are commercialized?

James M. Mock
Moderna, Inc. - CFO

Terrific. Yes. Well, first, thanks for having us, Salveen. Pleasure to be here. And thanks, everybody, for joining. Yes. So as we transition

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot